Absolutely - anyone can break into healthcare investment banking, and recently I’ve seen a ton of non-targets break into it. Honestly, being a non-target only means that you need to network more, but once you’re in the process, it doesn’t really matter what school you go to as long as you nail your technicals and have a solid story.

As far as why investment banking, I find that answer to be hugely personal. One thing I would note is that in healthcare banking, you also deal with a lot of capital raising (obviously in addition to mostly M&A). I’ve heard some great answers about wanting to help companies raise money to bring their products to more patients etc. However, as I said, the more real the response is, the better. Read healthcare news and see what sticks with you. It’s super obvious if people are really passionate about something, and that’s honestly one of the biggest factors for us while hiring.

 

1. How has HCIT changed over the past 5 years in the capital markets/M&A space? What are the trends you've noticed in strategic buyers / PE firms? 

2. Will HC providers consolidation ever slow down? Seems to always be a stable M&A market yet a lot of political views seem anti-consolidation.

3. Are there certain trends that strategic/corporate buyers look for in HC companies that sponsors don't? And vice versa?

4. What verticals are you bullish on? For ex: HC services? HCIT? Biotech? Medtech?

5. Is telemedicine losing its "appeal"? It was booming in 2020 but now the market seems to have cooled down. A lot of public companies and recent SPACs/IPO have not performed well. 

Thanks in advance.

 
Most Helpful

Oh boy loaded question haha. Let me see:

  1. So last year was huge for HCIT. Record M&A, record healthcare issuance. A lot of strategics have realized these capabilities are tough to develop internally so they resort to buying. You no longer just see consolidation and only big HCIT guys buying the smaller ones - big tech and medtech players are acquiring HCIT companies as well. For PE buyers, consolidation still matters - it’s a great way to patch together a bunch of different businesses and offer solutions across a broad set of needs
  1. Highly doubt it will slow down, especially with so many digital health VC-backed companies coming to life. There’s a ton of room to grow, healthcare is far from being great in this country, so new solutions keep emerging
  1. Synergies, but that’s for all strategics, not just strategics in this space. Ability to integrate with existing solutions is also another big one. Also keep in mind profitability - some public strategics can get penalized by the market if profitability is really far out, so that’s what sometimes pushes them to sidelines. A lot of time the most aggressive buyers are sponsor backed strategics
  1. Biotech hands down. People will keep being sick, and there is still so much opportunity. And yes, while the government keeps threatening with regulations surrounding drug pricing, the truth is that the US is an innovation hub and without proper incentives, R&D wouldn’t be a thing. If this topic interests you, I highly recommend reading Kolchinsky’s book - the TLDR for it is that insurance companies are to blame
  1. I wouldn’t say it’s telemedicine specific, the market has been down in general, especially with generalist investors rotating out of healthcare stocks post COVID. I personally think telemedicine solutions are amazing, especially for mental health
 

Tysm! I have an extensive healthcare background and am considering recruiting for IB at Bschool. I know these questions were loaded haha so I definitely appreciate it.

 

Thank you so much for being open to answer questions!

Currently heading into a Tier 3 BB with their healthcare services coverage group. Not in NY but in a LCOL city. Have a lot of interest in healthcare M&A teams at boutiques like HL and Provident.

What are other HC services groups to look into?

1.) Are you getting good modeling experience at your BB (Not just comps)? -if you're specifically in LS I know SOTP is solid experience.

2.) What are you thoughts on exits from HC IB? Are you interested in IB long term?

3.) I want to be a beast and know the industry really well. What daily reads, other resources would you recommend to be knowledgeable about the landscape? Any free primers?

Thanks again!

 

Of course, I’m happy to help!

  1. So I’m actually at an EB, not a BB. Modeling experience here is fantastic, and analysts truly own their models. When interviewing with places, don’t be shy and ask people about their modeling experience, I’ve heard that in some BBs analysts don’t have too hands on of an experience
  1. Excellent exits, I feel like outsiders can appreciate how hard healthcare IB people work given it requires keeping up with trends / more knowledge than other industries. I would get pinged by megafunds on a continuous basis, but for me personally, VC always sounded more enticing
  1. Great question, depends on what your focus is. If you’re in services like you mentioned, definitely read PE Hub. Also, are you still in college? If so, you probably have access to equity research. Read initiating coverage reports on different companies within your desired sector (whether it’s HCIT, value based care etc etc). The research analysts usually do amazing deep dive on the sectors, so it’s super helpful in picking up knowledge

Hopefully this is helpful!

 

Kind of related topic, but also slightly off-topic. Was recruiting for a HC group any different than what's "normal" in IB?

I'm coming from a HC background (hard sciences, research, HCIT consulting) in b school, and I'm guessing it makes the most sense for me to pitch myself to HC groups. 

 

Of course, happy to help! And you got that right, close to VP. Honestly I’ve seen it all over the years - analysts getting recruited to PE during their training without even knowing what they’re getting themselves into. For me, I want to understand what it is exactly that I’m getting into, and one of the biggest question is if I love the people.

I feel like IB gets a bad rep. Yes, we do work crazy hours, but to be completely honest, I absolutely love my group. I’m very close with all the Partners on the team, and the one I work closest with gives me insane opportunities to grow.

The one absolutely crazy thing I’ve seen analysts do is pick certain banks because of marginally better names than others without any regard to the group culture. What I tell everyone is yes, shoot for the stars, but only people you love working with will help you reach your true potential.

TLDR: I would jump off the bridge for my teammates

 

Depends on what your strengths are! Definitely review pharma DCFs (how do you estimate market size, probabilities of success, costs - clinical trial costs increasing with each Phase and ramp up in SG&A ahead of commercialization) and napkin merger models (company A acquires company B, if synergies are X is this deal accretive?).

If you’re interviewing for a more healthcare services focused HC BB, then probably more focus on services based valuation, maybe even concepts behind an LBO.

In either case, have your accounting concepts down and do a ton of practice questions. When practicing, ask yourself why you got questions wrong - it really helps!

 

First of all, congratulations!! For me personally, I was always excited about life sciences, and I love seeing companies grow throughout their life cycles - and you see a ton of that in life sciences!

With respect to corp dev exits, they’re definitely doable / I’ve seen quite a few BD director openings at large pharmas. It becomes even easier if you work with these companies and develop direct relationships. I would say definitely look at earlier stage companies as well - you’ll have more room to grow and usually great equity packages as well. Plus it’s really fun helping your company go through an IPO or M&A!

 

Thanks for the reply, appreciate the insight! During my networking with people in the industry, someone told me that "if you can model in healthcare, you can model in anything." Do you think that's true? And, if so, what makes modeling out healthcare firms more difficult/complicated than other industries? Maybe it's just a specific vertical (pharma, life sciences, biotech, e.g.) but would appreciate your thoughts on this sentiment. Thanks again!

 

Thanks for doing this! Do you think being in life sciences / pharma pigeonholes you into the sector? Thinking about recruiting for HC groups but not certain I want to stay in the HC long term and am looking about potential exits into PE.

 

Not necessarily! I’ve seen some great PE exits from people who have been in life sciences. The only thing I would say - if you feel strongly about PE, consider recruiting earlier in your career rather than later. I think if you are in life sciences IB until your VP years, it would be near impossible breaking into services oriented PE. But as long as you’re an analyst and you can study for PE technicals, you’ll be more than fine!

 

Best NYC HC franchises in your opinion? Love the healthcare space and really see myself in healthcare investing in the future.

 

Oh boy, that’s a loaded question. Honestly I think it’s very personality dependent, and it also depends on what you want out of your experience. For example, if you want to work on company positioning and helping them go public, go to Cowen because they have excellent equity franchise. If you want to do M&A only, go to Centerview. If you want broader product exposure (M&A and equities), go to Evercore. But in reality, I think the most important thing is the team. Get to know people on the team and see who you really vibe with - you’ll spend so much time with them, so you want to make sure you enjoy them!

 

Honestly I would say focus on making the most out of it. You never know, maybe you’ll absolutely fall in love with the group / team! If you feel like it’s not what you want to be doing, just do a ton of networking. Reach out to analysts at groups that you’re interested in and have an honest conversation about why you are looking to lateral. Just keep in mind most EBs have very high return rates, so openings after junior year internships are quite rare

 

After having so much experience in the industry, what have you really seen in a candidate that makes them stand out from the rest? Besides genuine passion, hard work ethic, and avoiding the cookie-cutter answers, any advice? 

Additionally, what makes you inclined to respond to a cold email. As someone who tries to be as specific and tailor it personally to them, I still have a 5-10% response rate. 

Huge thanks, it means a ton!

 

Honestly, have a personality outside investment banking. I love it when people have an interest section on their resume. It’s also amazing when candidates talk about volunteering experience they’ve done in the past - it shows they care about more than this job.

In terms of better odds on emailing.. how an email is written matters a ton. You’d be surprised how many candidates aren’t polite / write incredibly cookie cutter emails. Also always make sure to send thank you emails, they really matter. And never email us during the morning rush because your email will just get buried - between ~6-10pm is the sweet spot!

 

Hopefully not derailing this conversation, but HCIT feels like a lot of the quality sponsor-backed assets already had some sort of an exit event in the past 18 months (think 2H 2020 thru end of 2021). Therapy Brands, Provation, Quantum, GHX, symplr, PartsSource, Greenphire, MMIT, eSolutions, Wellsky, RLDatix, GoodRx, Multiplan, Qgenda, Cytel… Probably plenty of others that I missed, but there was definitely some pull forward in those past 18 months and 2022 should be interesting.

 

I’m not trying to go the PE route, so unfortunately don’t have the best answer. Have you spoken to recruiters? I would hit up CPI, Henkel, SG and Amity. Definitely get on their radars and make it clear that you’re looking to make a jump. In terms of biggest players in HC, I would say Blackstone, TPG, KKR, Warburg, but then also places like Arsenal, Clearlake (for HCIT) and Charlesbank

 

I am coming from a non-traditional background.  Currently working with program management team to get a CAPM through PMI to hopefully spearhead projects.  Also finishing an online BS in Public Health.  

How do firms view these experiences, and how would it translate into Healthcare IB?  I have always been interested in how healthcare is funded, how hospitals run, healthcare insurance policies.

Would a MBA or JD help further translate into this area?  

FWIW, I am in SD - CA.  So a smaller city compared to LA/NY/SF/Chicago.  However, we have a huge biotech/biopharm market!

 

Thank you for sharing your insights! I found your responses helpful! A few questions:

1. What do you find exciting/ interesting about HC banking?

2. If not HC banking, what would have been your next career choice?

3. Are skills transferable between life sciences and medtech, or is the person seen as a siloed specialist?

4. What questions would you ask prospective employers for an entry level position to determine if the firm is a good fit (either in life sciences or HC area)?

 

Hey! So:

  1. There’s always something new going on. I swear every single day is different. Not just newsflow, but also product exposure / type of work doing for clients. Also, not to sound cheesy, but our clients are doing amazing things that end up being life changing for many patients
  1. Hmmm… Healthcare VC or a cool healthcare startup. Getting more of that operating experience!
  1. Skills are definitely transferable, but the vertical is different in terms of newsflow. A lot of the newer medtech companies are adopting biotech valuation methodologies (ie no revenues from the beginning), so some of it is transferable! I would say diagnostics is closer to biotech than medtech though
  1. Ask about client exposure. Who is the team’s point person? Who is in charge of modeling? Who is in charge or the day to day workstreams? Also, would ask about culture - each firm has a different culture, so you want to make sure you pick one that fits you best!
 

I think they just have a much more narrow focus on specific industries (for example, I think Cain is amazing at healthcare facility rollups - like derm clinics). They don’t have as wide of an exposure and tend to serve one group of clients (middle market focused). Some people absolutely love these types of projects, so if you thrive in it, it’s the perfect fit!

 

Great question! I think there’s a ton of room in the space, aka huge potential for companies. Someone just needs to figure out how to do this right / how to make things painless for providers and administrators. The biggest issue is solving data entry - I get that a lot of companies can clean up data, but the issue with human biology is that 1) it’s complex 2) issues assessed can be interpreted very subjectively. I think if companies can figure out 1) EHR integration 2) ease of use for providers 3) overcoming clinical hurdles, that should set them up for success! Agree that Tempus is probably the one furthest ahead. We’ll see what the future has in this space.. maybe health records and clinical data in the blockchain? Would be super cool

 

I think so, but definitely don’t do it if you hate it. Honestly if you’re in sciences and you manage to have above 3.5, you’re golden. I personally majored in a bio-related field and absolutely loved it. I know there are some feeder programs into life sciences IB (like the Vagelos program at Penn), so we see quite a few candidates with both bio and finance majors

 
nicolaszacair

Do you think having a Biology second major is worth it?Really want to do Healthcare/Life sciences IB, so I decided to do bio second major, but it is lowering my Gpa around .2 points (sophomore rn).

So I probably know more about this than OP; if you're GPA is being lowered by taking a few biology classes I really don't think you're going to accel in Biotech banking to beggin with. Your better off taking a few fluff classes and sticking with something a bit less quantitative like Equity Research or even the generalist M&A group.

 

Hi, 

When I say its being lowered, I mean its dropped to the 3.7 range, not something outrageously low. Also its not bio classes, but rather OChem that I am struggling with a little bit. Even so, the real problem is the time commitment not that actual difficulty of the classes. If i was just a pure Bio major, I could pull off close to a 4.0, but having a second major and recruiting full time is what is dragging my GPA. 

I also legitimately enjoy the major. Do you think it is worth it?

 

Hi! Thanks for doing this. I'm curious to hear your thoughts on TripleTree given their incredible growth the past 2 years.

 

Delectus minus enim aut ut ea. Molestias et atque porro. Occaecati sequi accusantium saepe dolor quasi id. Assumenda asperiores qui distinctio illo dolorum.

 

Dolores omnis exercitationem quo voluptas unde. Est minus fugit sapiente velit quis ut. Animi tempora laborum voluptas. Rerum quis repellendus molestiae iste voluptatum. Rem eos cumque voluptatem et. Eaque magni in architecto saepe esse similique vero.

Autem eum quia voluptas voluptatibus est rem iusto. Quis dolorum est iure consequatur voluptatem. Placeat ut in facere aut ut unde. Illum ea quisquam vitae sunt et reprehenderit ab. Et sapiente ut quo et quam.

 

Dolorem sint velit quo ducimus. Maxime consequatur dolorem voluptatem consequatur aliquam excepturi.

Pariatur voluptatem dolorum corporis quo harum facilis. Est aut quod animi. Accusantium dolor quis quos qui molestias aut. Illo nesciunt aut illum et.

Et unde ut tenetur sed eius quo pariatur. Non ipsa tenetur unde dicta. Aut fuga necessitatibus dolor beatae. Aut ipsam aspernatur voluptas eos unde veritatis et. Quasi necessitatibus facilis quia cumque esse at voluptatem. Cum rem quam itaque sed. Eum animi tenetur a nam assumenda odit et.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”